Five men who used the heavily promoted testosterone supplement AndroGel manufactured by Abbott Laboratories and AbbVie Inc., a recently spun off subsidiary, have filed a lawsuit alleging the the company hid the dangers that the topical substance exposed them to increased risks of heart attack and stroke. Three of the men, aged 50 to 62, claim they suffered a heart attack, a fourth claims he suffered a stroke, and a fifth asserts he suffered a mini-stroke. The men claim that Abbott used retired professional athletes in marketing the drug while downplaying known and serious adverse health effects.
A study released in November of more than 8,000 men treated in the Veterans Health Administration found testosterone therapy raised the risk of heart attack, stroke and dying by 29 percent. Testosterone worsens sleep apnea and is linked to atherosclerosis and coronary plaque, the study found without identifying reasons why.
Read more at Reuters
If you or a loved one have used Androgel and have questions or concerns, contact attorney Ben Stewart at the Bryant Law Center in Paducah for a free consultation.